Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer

3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer

US Patent 9643964 · Granted May 9, 2017

Estimated economic value: $139,713,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phthalazinone based modulators for the treatment of disease2025
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof2025
Therapeutic compounds2024
Thiophene derivatives as antiviral agents2023
Benzoxazepin oxazolidinone compounds and methods of use2023
Meta tyrosine derivatives as rho-kinase inhibitors2023
Compounds useful as RET inhibitors2023
Heterocyclic compounds as RET kinase inhibitors2023
Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition2023
Fused thiophene derivatives and their uses2023
Heterocyclic compounds as RET kinase inhibitors2023
Fused thiophene derivatives and their uses2022